Literature DB >> 32004696

A composite of BMI and waist circumference may be a better obesity metric in Indians with high risk for type 2 diabetes: An analysis of NMB-2017, a nationwide cross-sectional study.

Murali Venkatrao1, Raghuram Nagarathna1, Suchitra S Patil1, Amit Singh1, S K Rajesh1, Hongasandra Nagendra2.   

Abstract

AIMS: Obesity measurement is a vital component of most type 2 diabetes screening tests; while studies had shown that waist circumference (WC) is a better predictor in South Asians, there is evidence that BMI is also effective. Our objective was to evaluate the efficacy of BMIWC, a composite measure, against BMI and WC.
METHODS: Using data from a nationwide randomized cluster sample survey (NMB-2017), we analyzed 7496 adults at high risk for type 2 diabetes. WC, BMI, and BMIWC were evaluated using Odds Ratio (OR), and Classification scores (Sensitivity, Specificity, and Accuracy). These were validated using Indian Diabetes Risk Score (IDRS) by replacing WC with BMI and BMIWC, and calculating Sensitivity, Specificity, and Accuracy.
RESULTS: BMIWC had higher OR (2·300) compared to WC (1·87) and BMI (2·26). WC, BMI, and BMIWC were all highly Sensitive (0·75, 0·81, 0·70 resp.). But BMIWC had significantly higher Specificity (0.36) when compared to WC and BMI (0.27 each). IDRSWC, IDRSBMI, and IDRSBMIWC were all highly Sensitive (0·87, 0·88, 0·82 resp.). But IDRSBMIWC had significantly higher Specificity (0·39) compared to IDRSWC and IDRSBMI (0·30, 0·31 resp.).
CONCLUSIONS: Both WC and BMI are good predictors of risk for T2DM, but BMIWC is a better predictor, with higher Specificity; this may indicate that Indians with high values of both central (high WC) and general (BMI > 23) obesity carry higher risk for type 2 diabetes than either one in isolation. Using BMIWC in IDRS improves its performance on Accuracy and Specificity.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anthropometric; BMI; Central fat; Obesity; Type 2 diabetes

Mesh:

Year:  2020        PMID: 32004696     DOI: 10.1016/j.diabres.2020.108037

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.

Authors:  Maobin Kuang; Guotai Sheng; Chong Hu; Song Lu; Nan Peng; Yang Zou
Journal:  Lipids Health Dis       Date:  2022-10-20       Impact factor: 4.315

2.  Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: Systematic review and meta-analysis.

Authors:  Jiayu Zhang; Jiawen Ye; Xinge Tao; Wenjing Lu; Xueqin Chen; Changqin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

3.  Association of obesity profiles with type 2 diabetes in Chinese adults: Findings from the China health and nutrition survey.

Authors:  Siting Zhang; Weiyi Li; Xiaofang Jia; Jiguo Zhang; Hongru Jiang; Liusen Wang; Huijun Wang; Bing Zhang; Zhihong Wang; Gangqiang Ding
Journal:  Front Nutr       Date:  2022-09-13

4.  Effects of Adiponectin on T2DM and Glucose Homeostasis: A Mendelian Randomization Study.

Authors:  Zefeng Chen; Yulan Bai; Xinyang Long; Qianqian Luo; Zheng Wen; Yuanfan Li; Shengzhu Huang; Yunkun Yan; Zengnan Mo
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-22       Impact factor: 3.168

5.  A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.

Authors:  Xintian Cai; Qing Zhu; Yuanyuan Cao; Shasha Liu; Mengru Wang; Ting Wu; Jing Hong; Ayguzal Ahmat; Xiayire Aierken; Nanfang Li
Journal:  Biomed Res Int       Date:  2021-05-14       Impact factor: 3.411

Review 6.  What Are the Clinical and Systemic Results of Periodontitis Treatment in Obese Individuals?

Authors:  Carina M Silva-Boghossian; Romulo S Dezonne
Journal:  Curr Oral Health Rep       Date:  2021-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.